Paper39160255
Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes.
Skerget S and 58 others. Nat Genet, 2024. Cited by 90 papers, by iCite.
Cite this record
ConductScience Library. Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes. Papers, record 39160255. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39160255
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Multiple Myeloma | Major topic |
| DNA Copy Number Variations | Major topic |
| Humans | |
| Gene Expression Regulation, Neoplastic | |
| Exome Sequencing | |
| Gene Expression Profiling | |
| Female | |
| Male | |
| Whole Genome Sequencing | |
| Longitudinal Studies | |
| Disease Progression | |
| Middle Aged |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA008748 | NCI NIH HHS | United States | P30CA008748 | PubMed and NIH | NIH RePORTER |
| CoMMpass Study | Multiple Myeloma Research Foundation (Multiple Myeloma Research Foundation, Inc.) | PubMed | PubMed |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 40490515 | Author Correction: Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes. | https://conductscience.org/library/papers/40490515 |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6335483 | Non-random chromosomal aberrations associated with multiple myeloma. | Hematol Oncol | 1984 | https://conductscience.org/library/papers/6335483 | PubMed |
| 2 | 19687334 | Prognostic significance of copy-number alterations in multiple myeloma. | J Clin Oncol | 2009 | https://conductscience.org/library/papers/19687334 | PubMed |
| 3 | 16616336 | High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients. | Cancer Cell | 2006 | https://conductscience.org/library/papers/16616336 | PubMed |
| 4 | 6609674 | Translocation t(11;14) and trisomy 11q13----qter in multiple myeloma. | Ann Genet | 1984 | https://conductscience.org/library/papers/6609674 | PubMed |
| 5 | 8943038 | Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma. | Proc Natl Acad Sci U S A | 1996 | https://conductscience.org/library/papers/8943038 | PubMed |
| 6 | 11418483 | Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to immunoglobulin loci in multiple myeloma. | Blood | 2001 | https://conductscience.org/library/papers/11418483 | PubMed |
| 7 | 11877296 | Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation. | Blood | 2002 | https://conductscience.org/library/papers/11877296 | PubMed |
| 8 | 15257707 | The recurrent translocation t(14;20)(q32;q12) in multiple myeloma results in aberrant expression of MAFB: a molecular and genetic analysis of the chromosomal breakpoint. | Br J Haematol | 2004 | https://conductscience.org/library/papers/15257707 | PubMed |
| 9 | 12805059 | The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma. | Blood | 2003 | https://conductscience.org/library/papers/12805059 | PubMed |
| 10 | 24429703 | Heterogeneity of genomic evolution and mutational profiles in multiple myeloma. | Nat Commun | 2014 | https://conductscience.org/library/papers/24429703 | PubMed |
| 11 | 24434212 | Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy. | Cancer Cell | 2014 | https://conductscience.org/library/papers/24434212 | PubMed |
| 12 | 26282654 | Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma. | J Clin Oncol | 2015 | https://conductscience.org/library/papers/26282654 | PubMed |
| 13 | 21430775 | Initial genome sequencing and analysis of multiple myeloma. | Nature | 2011 | https://conductscience.org/library/papers/21430775 | PubMed |
| 14 | 15809451 | International staging system for multiple myeloma. | J Clin Oncol | 2005 | https://conductscience.org/library/papers/15809451 | PubMed |
| 15 | 26240224 | Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group. | J Clin Oncol | 2015 | https://conductscience.org/library/papers/26240224 | PubMed |
| 16 | 17692805 | Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. | Cancer Cell | 2007 | https://conductscience.org/library/papers/17692805 | PubMed |
| 17 | 16728703 | The molecular classification of multiple myeloma. | Blood | 2006 | https://conductscience.org/library/papers/16728703 | PubMed |
| 18 | 20574050 | Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients. | Blood | 2010 | https://conductscience.org/library/papers/20574050 | PubMed |
| 19 | 25904160 | APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma. | Nat Commun | 2015 | https://conductscience.org/library/papers/25904160 | PubMed |
| 20 | 31439946 | MYC dysregulation in the progression of multiple myeloma. | Leukemia | 2020 | https://conductscience.org/library/papers/31439946 | PubMed |
Cited by76
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 90 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42959892 | A proliferation score defined by PCLI-anchored transcriptomics predicts outcomes in multiple myeloma. | Blood Neoplasia | 2026 | https://conductscience.org/library/papers/42959892 | PubMed |
| 42912512 | APOBEC Status Classification Using a Curated Gene Panel in Multiple Myeloma. | Hematol Oncol | 2026 | https://conductscience.org/library/papers/42912512 | PubMed |
| 42902310 | Iron homeostasis landscape informs patient survival and neoadjuvant chemotherapy response in cancer. | BioData Min | 2026 | https://conductscience.org/library/papers/42902310 | PubMed |
| 42897348 | Molecular predictors of minimal residual disease in newly diagnosed multiple myeloma treated with quadruplet therapy. | Nat Med | 2026 | https://conductscience.org/library/papers/42897348 | PubMed |
| 42738384 | Dynamic Prediction of Survival Outcomes in Multiple Myeloma. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42738384 | PubMed |
| 42704271 | Dynamic multimodal survival prediction in multiple myeloma integrating gene expression, longitudinal laboratory measurements, and treatment history. | Brief Bioinform | 2026 | https://conductscience.org/library/papers/42704271 | PubMed |
| 42702361 | Machine Learning-Derived Immune Gene Signature Predicts Prognosis and Therapeutic Vulnerabilities in Multiple Myeloma. | Cancer Sci | 2026 | https://conductscience.org/library/papers/42702361 | PubMed |
| 42697963 | KDM6A loss enhances oxidative phosphorylation uncovering tissue-level convergent evolution. | EMBO J | 2026 | https://conductscience.org/library/papers/42697963 | PubMed |
| 42680839 | A single-cell atlas of multiple myeloma defines malignant archetypes and proliferative states. | Nat Genet | 2026 | https://conductscience.org/library/papers/42680839 | PubMed |
| 42671911 | Phosphorylation Protects Oncogenic RAS from LZTR1-Mediated Degradation. | Blood Cancer Discov | 2026 | https://conductscience.org/library/papers/42671911 | PubMed |
| 42665737 | Real World Data and Its Impact on the Management of Plasma Cell Dyscrasias. | Curr Hematol Malig Rep | 2026 | https://conductscience.org/library/papers/42665737 | PubMed |
| 42602967 | TP53 mutation drives unique transcriptional and functional vulnerabilities independent of del(17p) in multiple myeloma. | iScience | 2026 | https://conductscience.org/library/papers/42602967 | PubMed |
| 42588711 | Skull-Base Plasmacytomas: A Systematic Review on Therapeutic Trends. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42588711 | PubMed |
| 42511618 | Extracellular Vesicles as Master Regulators of Immune Modulation in Multiple Myeloma. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511618 | PubMed |
| 42490832 | Prognostic Significance of Isolated Beta 2-Microglobulin Elevation in Thai Multiple Myeloma: Impact of Renal Function Assessment. | J Hematol | 2026 | https://conductscience.org/library/papers/42490832 | PubMed |
| 42426380 | Global burden of multiple myeloma(1990-2021) and projections up to 2035: a methodical analysis leveraging the global burden of disease 2021 study and Mendelian randomization. | J Egypt Natl Canc Inst | 2026 | https://conductscience.org/library/papers/42426380 | PubMed |
| 42424601 | Schlafen 11 Is Overexpressed in Multiple Myeloma and Undergoes Nucleolar Translocation in Response to Bortezomib. | Cancer Res Commun | 2026 | https://conductscience.org/library/papers/42424601 | PubMed |
| 42393044 | Expression profile of CASSIOPEIA patients refines prognostic value of MRD negativity in multiple myeloma. | Blood Cancer J | 2026 | https://conductscience.org/library/papers/42393044 | PubMed |
| 42352940 | Inhibition of Fibroblast Growth Factor Receptor 3 Signaling by Ponatinib Reduces Growth and Cytokine Production of Multiple Myeloma Cells. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42352940 | PubMed |
| 42284538 | Genomic Features Do Not Account for Differences in Multiple Myeloma Risk by Ancestry. | Blood Cancer Discov | 2026 | https://conductscience.org/library/papers/42284538 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39160255
GET https://conductscience.org/api/papers/v1/39160255/authors?page=2